Nab-paclitaxel Combined With Cadonilimab (AK104) for the Second-line Treatment of Advanced Gastric Cancer

NCT06349967 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

59

Enrollment

OTHER

Sponsor class

Conditions

Gastric Cancer

Interventions

DRUG: Nab-paclitaxel Combined With Cadonilimab (AK104)

Sponsor

West China Hospital